Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

International Union Against Tuberculosis and Lung Disease

Nom variantlari: The Union · UATLD

Davlat:
FR
ROR:
https://ror.org/037x4qk98
6
h-indeks
79
Iqtiboslar
25
Asarlar
46
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0358100613192520162017201820192020202120222024202520262016: Nashrlar 1, Iqtiboslar 52017: Nashrlar 2, Iqtiboslar 72018: Nashrlar 3, Iqtiboslar 62019: Nashrlar 2, Iqtiboslar 92020: Nashrlar 0, Iqtiboslar 102021: Nashrlar 7, Iqtiboslar 212022: Nashrlar 0, Iqtiboslar 32024: Nashrlar 0, Iqtiboslar 22025: Nashrlar 0, Iqtiboslar 22026: Nashrlar 0, Iqtiboslar 2

Iqtibos tarixi

0613192520162017201820192020202120222024202520262016: Iqtiboslar 52017: Iqtiboslar 72018: Iqtiboslar 62019: Iqtiboslar 92020: Iqtiboslar 102021: Iqtiboslar 212022: Iqtiboslar 32024: Iqtiboslar 22025: Iqtiboslar 22026: Iqtiboslar 2

Nashr tarixi

03581020162017201820192020202120222024202520262016: Nashrlar 12017: Nashrlar 22018: Nashrlar 32019: Nashrlar 22020: Nashrlar 02021: Nashrlar 72022: Nashrlar 02024: Nashrlar 02025: Nashrlar 02026: Nashrlar 0

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

03581020162017201820192020202120222024202520262016: h-indeks 22017: h-indeks 32018: h-indeks 32019: h-indeks 32020: h-indeks 52021: h-indeks 52022: h-indeks 52024: h-indeks 52025: h-indeks 62026: h-indeks 6

Eng koʻp iqtibos qilingan asarlar

  1. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?20213 iqtibos
  2. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–201820212 iqtibos
  3. Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan20171 iqtibos
  4. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis20191 iqtibos
  5. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan20211 iqtibos
  6. Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–201820210 iqtibos
  7. Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?20210 iqtibos
  8. Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?20210 iqtibos
  9. Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan20210 iqtibos